healthy controls underwent abdominal SWI and were assessed for serum iron markers. Phase values were measured and five grades of hepatic iron deposition were described by SWI. RESULTS: Patients with HBV infection (n = 327) and healthy controls (n = 50) were prospectively enrolled. In total, 77 (25.4%) patients with HBV infection had hepatic iron deposition as determined by SWI. Phase values were significantly different between patients with hepatic iron deposition compared with patients without hepatic iron deposition or controls, and were significantly different across different grades of hepatic iron deposition.
Introduction
It has been estimated that 350 million people worldwide are infected with hepatitis B virus (HBV), 15 -40% of whom develop W Lv, F Yan, M Zeng et al. SWI assessment of hepatic iron deposition in chronic hepatitis B liver cirrhosis. 1 Hepatic iron deposition is an important risk factor for cirrhosis; it may be involved in the progression of hepatic fibrosis and resistance to interferon combination therapy, 2 and may increase the risk of hepatocellular carcinoma. 3 The majority of the data on hepatic iron deposition have, however, been obtained in patients with haemochromatosis and chronic hepatitis C (HCV) infection, with relatively few data available for patients with chronic hepatitis B.
Hepatic iron deposition is clinically identified by the measurement of elevated serum iron markers, such as serum ferritin and transferrin saturation. 4 Liver biopsy is also frequently used to determine hepatic iron deposition and this method has, until recently, been considered to be the goldstandard. It is, however, an invasive and expensive procedure with low reproducibility and acceptability, particularly in patients requiring follow-up assessments. 5 In addition, the distribution of hepatic iron is not uniform, which can lead to sampling errors and a consequent reduction in the accuracy of hepatic biopsy. 6, 7 Magnetic resonance imaging (MRI) has emerged as a superior method for the noninvasive assessment of hepatic iron. 8 -11 Iron has paramagnetic properties and its deposition in the liver results in a decrease in the signal intensity of the liver on T2weighted MRI.
Susceptibility-weighted imaging (SWI) has been reported as a sensitive method for the measurement of paramagnetic elements such as iron, and traditionally has been used in the investigation of some neurological diseases including multiple sclerosis, Alzheimer's disease and Parkinson's disease. 12 -15 Data regarding the use of abdominal SWI for the assessment of hepatic iron deposition are limited. It has been demonstrated that SWI may be a more sensitive method than T1-, T2-or T2*weighted imaging, and could detect a greater number of siderotic nodules than T2*-weighted imaging with long time-toecho (TE). 16 This research did not, however, quantitatively assess hepatic iron deposition using phase values on SW images and was not exclusively conducted in patients with chronic HBV infection. 16 The present study quantitatively assessed hepatic iron deposition in adult patients with chronic HBV infection using an abdominal SWI technique. This method was then compared with the more traditional measure of serum iron markers. 
Patients and methods

STUDY POPULATION
MRI TECHNIQUES
Examination by MRI was performed with a 3.0 T whole-body system (MAGNETOM ® Verio 3T; Siemens Healthcare, Erlangen, Germany) using a standard 12-channel matrix coil. The following parameters of the transverse abdominal two-dimensional SWI sequence were used: field of view, 380 × 285 mm 2 ; matrix, 320 × 250; slices, 30; slice thickness/spacing, 5.0/1.0 mm; repetition time/TE, 150/10 ms; flip angle, 20°; highpass filter 32 × 32. Acquisition time was three breath-holds of 15 s each to cover the whole liver.
A newly developed multislice twodimensional gradient echo (GRE) sequence with postautoreconstruction processing was used for abdominal SWI. 16 Phase images and SW images were acquired. SW images were used for the detection of iron deposition, while liver iron concentrations were quantitatively assessed using phase images.
IRON DEPOSITION SCORES AND MEASUREMENT OF PHASE VALUES
The degree of iron deposition was graded as follows: 0, no iron deposition; 1, minimal deposition -few iron nodules observed throughout the liver parenchyma; 2, mild deposition -more iron nodules observed but with an area of less than half of the whole liver parenchyma; 3, moderate depositionthe area of iron nodules occupied more than half of the whole liver parenchyma but there were some normal liver signals; 4, heavy deposition -observation of many iron nodules distributed throughout the whole liver parenchyma with almost no normal liver signals.
Two independent assessors (W.L., J.M.) with > 3 years' experience in abdominal MRI -blinded to the clinical status of the patients and control subjects -independently reviewed the images and graded the degree of liver iron deposition. The degree of interobserver agreement on the presence of hepatic iron deposition was obtained for each image, and consensus was reached on cases that were graded differently between the two readers and used in the final analysis.
Due to the nonuniform deposition of hepatic iron and severe artifacts of the left hepatic lobes caused by the proximity of the heart and stomach, regions of interest were selected to include the entire right liver, avoiding large vessels or artifacts ( Fig. 1) . Phase values of the middle five to seven slices of tissue were measured and mean values were determined. Then, radian values were calculated according to the formula: radian values = phase values (л/4095). Data in phase images are shown on a scale of -4095 (corresponding to a radian value of -л) to 4095 (corresponding to a radian value of л).
LABORATORY TESTS
Blood samples were collected post-MRI after an overnight fast, using heparin as an anticoagulant, and were immediately centrifuged at 3000 rpm for 10 min (TDL-5A low speed desk top large capacity centrifuge), to collect serum. Most of the samples were used the same day; otherwise they were stored at 4°C and used within 3 days. Serum samples were tested for serum iron, ferritin, total iron binding capacity (TIBC) and transferrin, using spectrophotometry (7170A fully automatic biochemical analyser; Hitachi High-Technologies [Shanghai] W Lv, F Yan, M Zeng et al.
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International Trading Co. Ltd, Guangzhou, China) and electrochemiluminescence assays (Siemens BNP automatic specific protein analyser; Siemens, Erlangen, Germany) according to the manufacturers' instructions. Transferrin saturation was calculated using the formula: transferrin saturation (%) = serum iron × 100/TIBC. Examination of serum markers was performed between 0 and 15 days after MRI.
STATISTICAL ANALYSES
Statistical analyses were performed using SPSS ® statistical software, version 17.0 (SPSS Inc. Chicago, IL, USA) for Windows ® . Quantitative data were presented as mean ± SD or mean (minimum, maximum) and categorical variables as n (%). Univariate comparisons of continuous data were made using Student's t-test, or Mann-Whitney Utest for nonparametric data. The χ 2 -test was used to compare categorical data. Significant differences in phase values observed across grades 1 -4 of hepatic iron deposition were compared using analysis of variance. Spearman's rank correlation coefficient was used to analyse the correlation between SWI phase values and serum ferritin levels. To determine interobserver variability, κstatistics were performed. A P-value of < 0.05 was considered to be statistically significant.
Results
A total of 327 patients (201 males; 126 females) with chronic HBV infection and a mean ± SD age of 49.0 ± 13.5 years (range 21 -86 years) were enrolled in the study. In addition, 50 healthy volunteers (28 males, 22 females) with a mean ± SD age of 52.0 ± 10.5 years (range 25 -74 years) were recruited as controls. Data from 303 patients with HBV infection and 47 healthy controls were included in the analysis; 24 patients and three control subjects were excluded due to the severity of motion artifacts. Interobserver agreement for the determination of hepatic iron deposition using SWI was reached (κ = 0.95; Table 1 ). Of the patients included for data analysis, 77 (25.4%) were observed to have hepatic iron deposition on SWI; no control subject demonstrated hepatic iron deposition.
A significant difference in phase values was determined between patients with hepatic iron deposition and controls (P < 0.001), but not between patients without hepatic iron deposition and controls ( Table  2 ). There were no significant differences in age between patients with or without hepatic iron deposition or controls (Table 2) , although the ratio of male to female patients was significantly different in patients with hepatic iron deposition compared with patients without iron deposition and controls (P < 0.001; Table 3 ).
Of the 77 patients with hepatic iron deposition, 16 had grade 1, 33 had grade 2, 17 had grade 3 and 11 had grade 4 deposition (Fig. 2 ). Mean ± SD phase (radians) values for grades 1 -4 were -0.0352 ± 0.0086, -0.0563 ± 0.0091, -0.0852 ± 0.0101 and -0.1477 ± 0.0432, respectively. These values were significantly different across grades 1 -4 of hepatic iron deposition (F = 84.04; P < 0.001).
Mean levels of serum iron, ferritin, transferrin and transferrin saturation were significantly higher in patients with hepatic iron deposition compared with those without hepatic iron deposition (P < 0.001; Table 3 ). There was no significant difference in TIBC between patient groups. Levels of serum ferritin, serum iron and transferrin saturation increased with greater degrees of hepatic iron deposition, while TIBC and levels of transferrin decreased (Table 4 ). Only serum ferritin demonstrated a significant difference across grades 1 -4 of iron deposition (P = 0.036; Table 4 ). A low inverse correlation was detected between phase values and serum ferritin (r = -0.365; P = 0.007).
Discussion
To our knowledge, few studies have used abdominal SWI to assess hepatic iron deposition quantitatively in patients with chronic HBV infection. The abdominal SWI sequence used in the present study was a two-dimensional breath-hold GRE technique rather than the three-dimensional GRE acquisition previously used in brain imaging. 13 -15,17 This method was selected because the three-dimensional GRE sequence has been associated with breathing artifacts, long acquisition time and cusp artifacts caused by severe B 0 inhomogeneity in a multichannel system. 16 Using two-and three-dimensional GRE sequences, phase values have been shown to vary linearly with iron concentration, 17 suggesting that they could be used to assess iron content quantitatively in SWI-filtered phase images.
In SWI sequences, phase images contain Hepatic iron deposition grades: 1, minimal deposition -few iron nodules observed throughout the liver parenchyma; 2, mild deposition -more iron nodules observed but with an area of less than half of the whole liver parenchyma; 3, moderate deposition -the area of iron nodules occupied more than half of the whole liver parenchyma but there were some normal liver signals; 4, heavy deposition -observation of many iron nodules distributed throughout the whole liver parenchyma with almost no normal liver signals.
TABLE 3: Demographic characteristics and levels of serum iron, total iron binding capacity (TIBC), ferritin, transferrin and transferrin saturation in patients with chronic hepatitis B infection with or without hepatic iron deposition, as determined by susceptibility-weighted imaging
NS, not statistically significant (P ≥ 0.05).
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magnetic susceptibility information; materials with large magnetic susceptibilities (such as ferritin and haemosiderin) can create inhomogeneities in the local magnetic field, which accelerate proton dephasing and result in T2 relaxation of tissues. 18 Pathologically, hepatic iron deposits have been shown to exist in the form of haemosiderin and ferritin, 19 both of which may be sensitively detected by abdominal SWI sequences of the liver. Indeed, it has been demonstrated that abdominal SWI is more sensitive than T1-, T2and T2*-weighted imaging in detecting siderotic nodules in the cirrhotic liver. 16 Higher iron concentrations may cause greater magnetic field inhomogeneities, resulting in negative phase shifts. 20 Based on this theory, measurement of phase values could be used to assess hepatic iron concentrations quantitatively.
The present study demonstrated that there were significant differences in phase values between healthy control subjects and patients with hepatic iron deposition, but not those without hepatic iron deposition. Furthermore, different phase values were observed across different grades of hepatic iron deposition. This suggests that SWI phase values may be a potential method to determine the presence of iron deposition in patients with chronic HBV infection.
The present study also demonstrated that a quarter of the patients with chronic HBV infection had hepatic iron deposition, the grades of which were mostly mild and moderate. Similar results have been reported in patients with HCV 2 -4, 19 and it has been suggested that hepatic iron deposition may be associated with chronic necroinflammatory hepatocytic damage in these patients. 21 It is possible that a similar process might occur in patients with chronic HBV infection and hepatic iron deposits.
Levels of serum iron, ferritin, transferrin and transferrin saturation were significantly higher in patients with hepatic iron deposition compared with those without, in the present study. The level of serum TIBC was lower in patients with hepatic iron deposition compared with those without, although this difference was not statistically significant. Transferrin is the primary serum irontransport protein in blood and TIBC measures the maximum amount of iron attached to transferrin. 22 In patients with hepatic iron deposition, iron deposited in hepatocytes could inhibit synthesis of TIBC. 23 Only serum ferritin levels were found to be significantly different across different grades of hepatic iron deposition in the present study, and a low inverse correlation between phase values and serum ferritin was observed. High serum ferritin levels are significantly associated with older age, male gender, high body mass index, high alcohol intake and the presence of nonalcoholic fatty liver disease. 24 Levels are also raised as part of an acute-phase response or in dysmetabolic conditions. 25, 26 Abdominal SWI does not appear to be influenced by these factors, and it has been reported to be more sensitive in the detection of hepatic iron deposition than T2*-weighted imaging, which has been shown to have a sensitivity of 80%. 27 Thus, it appears that abdominal SWI can distinguish between the grades of hepatic iron deposition more sensitively than serum iron markers, since greater negative phase shifts were observed with increasing severity of iron deposition, while serum ferritin only appeared to be sensitive to greater hepatic deposition.
The present study was limited by the fact that no pathological diagnosis of liver iron concentration was obtained and, as such, it is not possible to determine the degree of misclassification of SWI. Inclusion of a normal control group does, however, indirectly demonstrate the potential validity of abdominal SWI.
In conclusion, the present study demonstrated that abdominal SWI may represent a powerful tool to assess liver iron overload noninvasively and quantitatively, compared with serum iron markers, in patients with chronic HBV infection.
